Skip Navigation

Drugmakers Are Set to Pay 23andMe Millions to Access Consumer DNA

www.bloomberg.com Drugmakers Are Set to Pay 23andMe Millions to Access Consumer DNA

GSK will pay the DNA testing company $20 million for non-exclusive access to genetic data.

Drugmakers Are Set to Pay 23andMe Millions to Access Consumer DNA
40
40 comments
40 comments